SALMONELLA ENTERICA И СИСТЕМА ЦИТОКИНОВ ХОЗЯИНА
- Авторы: Железникова Г.Ф1, Волохова О.А1
-
Учреждения:
- НИИ детских инфекций, Санкт-Петербург
- Выпуск: Том 86, № 5 (2009)
- Страницы: 98-104
- Раздел: Статьи
- Дата подачи: 09.06.2023
- Дата публикации: 15.10.2009
- URL: https://microbiol.crie.ru/jour/article/view/13364
- ID: 13364
Цитировать
Полный текст
Аннотация
В обзоре представлены современные сведения о механизмах иммунной защиты при сальмонеллезной инфекции, способности сальмонелл противостоять этим механизмам. Основной акцент сделан на реакции системы цитокинов врожденного и приобретенного иммунитета, описанной в экспериментальных и клинических исследованиях.
Ключевые слова
Полный текст
SALMONELLA ENTERICA И СИСТЕМА ЦИТОКИНОВ ХОЗЯИНА×
Об авторах
Г. Ф Железникова
НИИ детских инфекций, Санкт-Петербург
О. А Волохова
НИИ детских инфекций, Санкт-Петербург
Список литературы
- Железникова Г.Ф. Роль гамма-интерферона в иммунопатогенезе инфекций. Клин. лаб. диагн. 2008, 4: 3-8.
- Кетлинский С.А., Симбирцев А.С. Цитокины. СПб, Фолиант, 2008.
- Мартынова Н.Н., Аленов М.Н., Пак С.Г., Умбетова К. Динамика содержания цитокинов и газового состава крови больных сальмонеллезом и острым шигеллезом. Тер. архив. 2006, 78 (11): 24-27.
- Поздеев О.К., Федоров Р.В. Энтеробактерии. М., Гэотар-Медиа, 2007.
- Романова Ю.М., Щегловитова О.Н., Бошнаков Р.К. и др. Активация размножения Salmonella typhimurium в органах зараженных животных при действии ФНО-α и острого γ-облучения. Rus. J. Immunol. 2002, 7 (2): 129-134.
- Bao S., Beagley K., France M. et al. Interferongamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunol. 2000, 99 (3): 464-472.
- Berin M., Dwinell M., Eckmann L., Kagnoff M. Production of MDC/CCL22 by human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280 (6): G217-226.
- Berntman E., Rolf J., Johansson C. et al. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur. J. Immunol. 2005, 35 (7): 2100-2109.
- Bueno S., González P., Schwebach J., Kalergis A. T cell immunity evasion by virulent Salmonella enterica. Immunol. Lett. 2007, 111 (1): 14-20.
- Cook P., Tötemeyer S., Stevenson C. et al. Salmonella-induced SipB-independent cell death requires Toll-like receptor-4 signalling via the adapter proteins Tram and Trif. Immunol. 2007, 122 (2): 222-229.
- Depaolo R., Lathan R., Rollins B., Karpus W. The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection. Infect. Immun. 2005, 73 (10): 6514-6522.
- Dharmana E., Keuter M., Netea M. et al. Divergent effects of TNF-α and lymphotoxin-α on lethal endotoxemia and infection with live Salmonella typhimurium in mice. Eur. Cytokine Netw. 2002, 13 (1): 104-109.
- Diepen van A., Martina C., Flierman R. et al. Treatment with anti-TNF-α does not induce reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice. Scand. J. Immunol. 2007, 65 (5): 407-411.
- Eckmann L., Kagnoff M. Cytokines in host defense against Salmonella. Microbes Infect. 2001, 3 (14-15): 1191-1200.
- Elhofy A., Marriott I., Bost K. Salmonella infection does not increase expression and activity of the high affinity IL-12 receptor. J. Immunol. 2000, 165 (6): 3324-3332.
- Fahy O., Townley S., Coates N. et al. Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3α/CCL20. Lab. Invest. 2004, 84 (11): 1501-1511.
- Fahy O., Townley S., McColl S. CXC16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gammainterferon production. Infect. Immun. 2006, 74 (12): 6885-6894.
- Fieschi C., Casanova J. The role of IL-12 in human infectious diseases: only a faint signature. Eur. J. Immunol. 2003, 33 (6): 1461-1464.
- Gajendran N., Mittrücker H., Bordasch K. et al. Regional IFN-γ expression is insufficient for efficacious control of food-borne bacterial pathogens at the gut epithelial barrier. Int. Immunol. 2007, 19 (9): 1075-1081.
- Galdiero M., Marcatili A., Cipollaro de l’Ero G. et al. Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice. Infect. Immun. 1999, 67 (3): 1432-1438.
- Gerlach R., Hensel M. Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica. Berl. Munch. Tierarztl. Wochenschr. 2007, 120 (7-8): 317-327.
- Godinez I., Rafatellu M., Chu H. et al. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect. Immun. 2009, 77 (1): 387-398.
- Harrington L., Srikanth C., Antony R. et al. A role for natural killer cells in intestinal inflammation caused by infection with Salmonella enterica serovar Typhimurium. FEMS Immunol. Med. Microbiol. 2007, 51 (2): 372-380.
- Izadpanah A., Dwinell M., Eckmann L. et al. Regulated MIP-3α/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280 (4): G710-719.
- John B., Rajagopal D., Pashine A. et al. Role of IL-12-independent pathways in regulating generation of IFN-γ component of T cell responses to Salmonella typhimurium. J. Immunol. 2002, 169 (5): 2545-2552.
- Kirby A., Yrlid U., Wick M. The innate immune response differs in primary and secondary Salmonella infection. Ibid. 2002, 169 (8): 4450-4459.
- Koebernick H., Grode L., David J. et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA. 2002, 99 (21): 13681-13686.
- Layton A., Galyov E. Salmonella-induced enteritis: molecular pathogenesis and therapeutic implications. Expert. Rev. Mol. Med. 2007, 9 (18): 1-17.
- Lehmann J., Bellmann S., Werner C. et al. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J. Immunol. 2001, 167 (9): 5304-5315.
- Lin A., Lin C., Chen C., Chen W. Host defense against Salmonella and rotaviral gastroenteritis: a serial study of transcriptional factors and cytokines. J. Microbiol. Immunol. Infect. 2008, 41 (3): 265-271.
- Maaser C., Eckmann L., Paesold G. et al. Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology. 2002, 122 (3): 667-680.
- MacLennan C., Fieschi C., Lammas D. et al. IL-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 2004, 190 (10): 1755-1757.
- Mastroeni P. Immunity to systemic Salmonella infection. Curr. Mol. Med. 2002, 2 (4): 393-406.
- Mittrücker H., Köhler A., Kaufmann S. Charac- terization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2002, 70 (1): 199-203.
- Mizuno Y., Takada H., Nomura A. et al. Th1- and Th2-inducing cytokines in Salmonella infection. Clin. Exp. Immunol. 2003, 131 (1): 111-117.
- Monack D., Navarre W., Falkow S. Salmonellainduced macrophage death: the role of caspase-1 in death and inflammation. Microbes Infect. 2001, 3 (14-15): 1201-1212.
- Monack D., Bouley D., Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nrampl1+/+ mice and can be reactivated by IFN-γ neutralization. J. Exp. Med. 2004, 199 (2): 231-241.
- Naiki Y., Nishimura H., Itohara S., Yoshikai Y. γδ T cells may dichotomously modulate infection with avirulent Salmonella choleraesuis via IFN-γ and IL-13 in mice. Cell. Immunol. 2000, 202 (1): 61-69.
- Netea M., Fantuzzi G., Kullberg B. et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 2000, 164 (5): 2644-2649.
- Ottenhoff T., Verreck F., Lichtenauer-Kaligis E. et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 2002, 32 (1): 97-105.
- Pascual D. The protective role of IL-18 in Salmonella infection. Curr. Opin. Infect. Dis. 2001, 14 (3): 265-271.
- Pietilä T., Veckman V., Kyllönen P. et al. Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells. J. Leukoc. Biol. 2005, 78 (4): 909-920.
- Price J., Simpendorfer K., Mantena R. et al. Gamma-IFN-independent effects of IL-12 on immunity to Salmonella enterica serovar Typhimurium. Infect. Immun. 2007, 75 (12): 5753-5762.
- Raupach B., Peuschel S., Monack D., Zychlinsky A. Caspase-1-mediated activation of IL-1β and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Ibid. 2006, 74 (8): 4922- 4926.
- Sashinami H., Yamamoto T., Nakane A. The cytokine balance in the maintenance of a persistent infection with Salmonella enterica serovar Typhimurium in mice. Cytokine. 2006, 33 (4): 212-218.
- Sebastiani G., Blais V., Sancho V. et al. Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strains. Infect. Immun. 2002, 70 (4): 1997- 2009.
- Srinivasan A., Salazar-González R., Jarcho M. et al. Innate immune activation of CD4 T cells in salmonella-infected mice is dependent on IL-18. J. Immunol. 2007, 178 (10): 6342-6349.
- Stoycheva M., Murdjeva M. Serum levels of IFN-γ, IL-12, TNF-α, and IL-10, and bacterial clearance in patients with gastroenteric Salmonella infection. Scand. J. Infect. Dis. 2005, 37 (1): 11-14.
- Sundquist M., Rydström A., Wick M. Immunity to Salmonella from a dendritic point of view. Cell. Microbiol. 2004, 6 (1): 1-11.
- Wick M. Living in the danger zone: innate immunity to Salmonella. Curr. Opin. Microbiol. 2004, 7 (1): 51-57.
- Wick M. Monocyte and dendritic cell recruitment and activation during oral Salmonella infection. Immunol. Lett. 2007, 112 (2): 68-74.